(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADVERUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADVERUM

ST13

US500000079194977

Class

5

Filing

79194977

Registration

5303797

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

06/05/2026

Trademark type

Word

Nice classes

5

Filing date

07/25/2016

Registration date

10/10/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/03/2024

Last transaction

06/05/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

US

Examiner

HUSSAIN, TASNEEM

Current location

Historical data usage

Holders and representatives

Holders

Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc.

Representatives

Linda Joy Kattwinkel Owen, Wickersham & Erickson, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/04/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/03/2024

71AG

REGISTERED-SEC.71 ACCEPTED

07/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/21/2024

ES71

TEAS SECTION 71 RECEIVED

09/29/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/04/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/20/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/10/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/16/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/20/2018

FIMP

FINAL DISPOSITION PROCESSED

01/20/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/10/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/14/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/18/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/18/2017

PUBO

PUBLISHED FOR OPPOSITION

07/25/2017

NPUB

NOTICE OF PUBLICATION

07/05/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/20/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/14/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/08/2017

ALIE

ASSIGNED TO LIE

06/02/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2017

RFNT

REFUSAL PROCESSED BY IB

11/25/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/10/2016

RFRR

REFUSAL PROCESSED BY MPU

11/10/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/05/2016

MAFR

APPLICATION FILING RECEIPT MAILED

11/05/2016

CNRT

NON-FINAL ACTION WRITTEN

11/04/2016

DOCK

ASSIGNED TO EXAMINER

11/04/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/01/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/27/2016

Continuous trademark protection

Get notified about every new filing that threatens ADVERUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.